177 related articles for article (PubMed ID: 23077301)
21. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
Kumar J; Yadav VN; Phulera S; Kamble A; Gautam AK; Panwar HS; Sahu A
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724763
[TBL] [Abstract][Full Text] [Related]
22. Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus.
Spiller OB; Blackbourn DJ; Mark L; Proctor DG; Blom AM
J Biol Chem; 2003 Mar; 278(11):9283-9. PubMed ID: 12645526
[TBL] [Abstract][Full Text] [Related]
23. Structure-function relationships of complement receptor type 1.
Krych-Goldberg M; Atkinson JP
Immunol Rev; 2001 Apr; 180():112-22. PubMed ID: 11414353
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the active sites in decay-accelerating factor.
Kuttner-Kondo LA; Mitchell L; Hourcade DE; Medof ME
J Immunol; 2001 Aug; 167(4):2164-71. PubMed ID: 11490001
[TBL] [Abstract][Full Text] [Related]
25. Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases.
Krych-Goldberg M; Hauhart RE; Subramanian VB; Yurcisin BM; Crimmins DL; Hourcade DE; Atkinson JP
J Biol Chem; 1999 Oct; 274(44):31160-8. PubMed ID: 10531307
[TBL] [Abstract][Full Text] [Related]
26. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
Seya T; Holers VM; Atkinson JP
J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
[TBL] [Abstract][Full Text] [Related]
27. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
28. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function.
Blom AM; Webb J; Villoutreix BO; Dahlbäck B
J Biol Chem; 1999 Jul; 274(27):19237-45. PubMed ID: 10383431
[TBL] [Abstract][Full Text] [Related]
29. Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.
Bernet J; Mullick J; Panse Y; Parab PB; Sahu A
J Virol; 2004 Sep; 78(17):9446-57. PubMed ID: 15308738
[TBL] [Abstract][Full Text] [Related]
30. Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules.
Yadav VN; Pyaram K; Ahmad M; Sahu A
J Immunol; 2012 Aug; 189(3):1431-9. PubMed ID: 22732591
[TBL] [Abstract][Full Text] [Related]
31. Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis.
Hair PS; Echague CG; Sholl AM; Watkins JA; Geoghegan JA; Foster TJ; Cunnion KM
Infect Immun; 2010 Apr; 78(4):1717-27. PubMed ID: 20100856
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.
Avirutnan P; Fuchs A; Hauhart RE; Somnuke P; Youn S; Diamond MS; Atkinson JP
J Exp Med; 2010 Apr; 207(4):793-806. PubMed ID: 20308361
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus regulates activation and processing of the third component of complement.
Mold C; Bradt BM; Nemerow GR; Cooper NR
J Exp Med; 1988 Sep; 168(3):949-69. PubMed ID: 2844953
[TBL] [Abstract][Full Text] [Related]
34. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
Nilsson SC; Karpman D; Vaziri-Sani F; Kristoffersson AC; Salomon R; Provot F; Fremeaux-Bacchi V; Trouw LA; Blom AM
Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897
[TBL] [Abstract][Full Text] [Related]
35. Complement receptor is an inhibitor of the complement cascade.
Iida K; Nussenzweig V
J Exp Med; 1981 May; 153(5):1138-50. PubMed ID: 6910481
[TBL] [Abstract][Full Text] [Related]
36. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
Iwata K; Seya T; Yanagi Y; Pesando JM; Johnson PM; Okabe M; Ueda S; Ariga H; Nagasawa S
J Biol Chem; 1995 Jun; 270(25):15148-52. PubMed ID: 7541036
[TBL] [Abstract][Full Text] [Related]
37. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
Meri S; Pangburn MK
Eur J Immunol; 1990 Dec; 20(12):2555-61. PubMed ID: 2148521
[TBL] [Abstract][Full Text] [Related]
38. Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity.
Bernet J; Ahmad M; Mullick J; Panse Y; Singh AK; Parab PB; Sahu A
Vaccine; 2011 Oct; 29(43):7435-43. PubMed ID: 21803094
[TBL] [Abstract][Full Text] [Related]
39. New member of the multigene family of complement control proteins in herpesvirus saimiri.
Albrecht JC; Fleckenstein B
J Virol; 1992 Jun; 66(6):3937-40. PubMed ID: 1316492
[TBL] [Abstract][Full Text] [Related]
40. Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement.
Rawal N; Rajagopalan R; Salvi VP
J Biol Chem; 2008 Mar; 283(12):7853-63. PubMed ID: 18204047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
